KCT0004515
Recruiting
未知
Development of a new immunochemistry method using antibodies of ARS group and AIMP2-DX2 in the pancreatic cancer cell
Yonsei University Health System, Gangnam Severance Hospital0 sites100 target enrollmentTBD
ConditionsNeoplasms
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Neoplasms
- Sponsor
- Yonsei University Health System, Gangnam Severance Hospital
- Enrollment
- 100
- Status
- Recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Patients with pancreatic cancer confirmed by imaging (CT, MRI, PET\-CT)
- •2\. Patients with pancreatic cancer diagnosed using cytology by endoscopic ultrasound
- •3\. Patients who underwent surgical treatment with pancreatic cancer
Exclusion Criteria
- •1\. Minors under the age of 19, vulnerable subjects such as illiteracy
- •2\. Excludes necrotic specimens
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Development of a new immunochemistry method using antibodies of proteins related bile duct cancer in the bile duct cancer cell; pilot studyNeoplasmsKCT0003285Yonsei University Health System, Gangnam Severance Hospital100
Not yet recruiting
Not Applicable
Development of a new immunochemistry method using antibodies of proteins related pancreatic cancer in the pancreatic cancer cellKCT0006134Yonsei University Health System, Gangnam Severance Hospital50
Recruiting
Not Applicable
Evaluation of an immunochromatography-based rapid antigen test for ocular infectionsOcular herpesvirus infectionJPRN-UMIN000050932Oita University150
Completed
Not Applicable
Experimental protocols for investigating immunogenicity to biopharmaceuticals in patients with immune mediated inflammatory disease (IMIDs)Rheumatoid arthritis10003816NL-OMON45746Academisch Medisch Centrum108
Active, not recruiting
Not Applicable
Implementation of mailed colon cancer screening testingISRCTN22187559Minneapolis VA Health Care System9,000